Monovalent vaccines are out and bivalent vaccines are in. On April 18, 2023, the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) for Moderna and Pfizer-BioNTech’s bivalent mRNA COVID-19 vaccines. Changes were made to simplify the vaccination schedule and authorize the current bivalent vaccines to be used for all doses. The […]
The post FDA Amends COVID-19 Vaccine Emergency Use Authorizations appeared first on AAPC Knowledge Center.